Exhibit 10.2
FIRST AMENDMENT TO SUBLEASE AGREEMENT
THIS FIRST AMENDMENT TO SUBLEASE AGREEMENT (this “Amendment”) is
made as of July 9, 2020, by and between Surface Oncology, Inc., a Delaware corporation (“Sublessor”), and EQRx, INC., a Delaware Corporation (“Sublessee”).
RECITALS
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
Promptly after the occurrence of the Effective Date, Sublessor and Sublessee shall confirm the Effective Date in writing.
Work Letter. (a)The first paragraph of Section 1 of the Work Letter shall be amended by adding after (“Second Amendment”) the following:
“and the Third Amendment to Lease dated as of April 30, 2020 (“Third Amendment”)”
(b) The second paragraph of Section 1 of the Work Letter shall be amended by adding after each instance of “Second Amendment” the following:
“and Third Amendment”
3. | Miscellaneous. |
(Signatures on following page.)
IN WITNESS WHEREOF, Sublessor and Sublessee have duly executed this Amendment as an instrument under seal, as of the day and year first above written.
SUBLESSOR:
By: /s/ Jeff Goater 7/9/2020
By: /s/ Melanie Nallicheri 7/9/2020
Name: Melanie Nallicheri
Title: President & COO